About calfactant
Pulmonary surfactant replacement
Used for
- Prevention and treatment of respiratory distress syndrome in premature infants
Usual dose in children
105 mg/kg intratracheally, usually in four doses about 12 hours apart; administered by trained clinicians.
Common side effects
- Slow heart rate
- Low blood oxygen
- Airway blockage
- Reflux into the breathing tube
Important warnings
- Given only into the lungs by trained clinicians.
- Breathing and oxygen levels can change rapidly during administration.
- May require temporarily adjusting ventilator settings.
- Not for administration into a vein.
Pregnancy
Not applicable; used in newborn infants.
Breastfeeding
Not applicable; used in newborn infants.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.